| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (constitutively erm(C)) |
>128 |
>128 |
>128 － ? |
Telithromycin (HMR 3647, RU-66647, Ketek)  |
1111 |
| Staphylococci (erm(C)-inducible) |
0.03 |
0.12 |
0.015 － 0.12 |
Cethromycin (ABT-773) |
1111 |
| Staphylococci (erm(C)-inducible) |
0.12 |
0.25 |
0.06 － 0.5 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
1111 |
| Staphylococci (erm(C)-inducible) |
>128 |
>128 |
1 － >128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1111 |
| Staphylococci (erythromycin-susceptible) |
0.03 |
0.06 |
≤0.015 － 0.06 |
Cethromycin (ABT-773) |
1111 |
| Staphylococci (erythromycin-susceptible) |
0.06 |
0.12 |
≤0.015 － 0.25 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
1111 |
| Staphylococci (erythromycin-susceptible) |
0.25 |
0.5 |
0.06 － 0.5 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1111 |
| Staphylococci (GC 4547 + coagulase-negative + methicillin-resistant) |
- |
- |
0.03 － ? |
AC98-6446 |
175 |
| Staphylococci (GC 4549 + coagulase-negative) |
- |
- |
0.015 － ? |
AC98-6446 |
175 |
| Staphylococci (group A) |
0.004 |
0.004 |
0.002 － 0.008 |
RWJ-5442 |
178 |
| Staphylococci (group A) |
0.015 |
0.015 |
0.008 － 0.015 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
178 |
| Staphylococci (group A) |
0.015 |
0.015 |
0.015 － 0.03 |
Cefotaxime (Cephotaxime, Claforan) |
178 |
| Staphylococci (group A) |
0.25 |
0.25 |
0.25 － ? |
Quinupristin/Dalfopristin (Synercid) |
178 |
| Staphylococci (group A) |
>0.25 |
>64 |
0.125 － >64 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
178 |
| Staphylococci (group A) |
0.5 |
64 |
0.5 － 64 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
178 |
| Staphylococci (group A) |
1 |
1 |
0.5 － ? |
Vancomycin (Vancocyn, Lyphocin) |
178 |
| Staphylococci (group A) |
1 |
2 |
0.5 － 4 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
178 |
| Staphylococci (group B) |
0.046 |
0.008 |
0.004 － 0.008 |
RWJ-5442 |
178 |
| Staphylococci (group B) |
0.06 |
0.06 |
0.03 － 0.06 |
Cefotaxime (Cephotaxime, Claforan) |
178 |
| Staphylococci (group B) |
0.06 |
0.06 |
0.03 － 0.06 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
178 |
| Staphylococci (group B) |
0.25 |
32 |
0.25 － >64 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
178 |
| Staphylococci (group B) |
0.5 |
0.5 |
0.5 － ? |
Quinupristin/Dalfopristin (Synercid) |
178 |
| Staphylococci (group B) |
1 |
1 |
0.5 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
178 |
| Staphylococci (group B) |
2 |
2 |
1 － 2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
178 |
| Staphylococci (group B) |
64 |
64 |
0.5 － 64 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
178 |
| Staphylococci (group C) |
0.5 |
2 |
0.5 － 2 |
Quinupristin/Dalfopristin (Synercid) |
178 |
| Staphylococci (group C) |
- |
- |
0.004 － 0.008 |
RWJ-5442 |
178 |
| Staphylococci (group C) |
- |
- |
0.007 － 0.015 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
178 |